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Madam, the use of peripherally inserted central catheters 
(PICC) has expanded rapidly in recent years. PICCs are 
perceived to be a safe and effective form of venous access 
with certain advantages over others such as ease of 
placement, lower rate of complications compared to non-
tunnelled central venous catheters, and longevity 
allowing home administration of drugs. However, a large 
number of complications associated with PICCs are being 
recognized increasingly such as thromboembolism and 
trauma to the vessels eventually causing central venous 
stenosis. This can have very significant implications for 
patients suffering from chronic kidney disease (CKD) who 
are at risk for progression to kidney failure and eventually 
require haemodialysis (HD).1 It is of paramount 
importance to maintain integrity of veins to provide a 
future haemodialysis vascular access for these patients. 
PICC lines may cause local trauma to vessels and hence 
may preclude future vascular access creation and its 
longevity. Due to multiple comorbid conditions, patients 
with CKD are more likely to have PICCs potentially 
increasing their risk for loss of veins.2 A strong and 
independent association between PICC use and lack of a 
functioning arterio-venous fistula has been proven in a 
case-control study of HD patients.3 Guidelines have been 
developed by various societies to prevent future access 
failure in CKD patients. The American Society of 
Nephrology, National Kidney Foundation Kidney Disease 
Outcomes Quality Initiative (KDOQI) and the Fistula First 
Breakthrough Initiative (FFBI) recommend against PICC 
use in patients at risk for or with known stage 3, stage 4 or 
5 CKD without consulting a nephrologist.4-6 
It is essential to understand that vein protection must 
begin long before initiation of HD is needed. It cannot be 
over emphasized that the potential long-term 
consequences of the PICCs must be weighed against their 
short-term convenience in CKD patients. The ultimate 
responsibility lies with nephrology community to educate 
non-nephrologist clinicians about the need to have vein 
protection strategies aimed at preserving future HD 
access. Moreover, given the fact that PICC insertion occurs 
most commonly in the hospital setting, there is a pressing 
need to apprise the practitioners/clinicians of careful 
selection of patients. Furthermore, there is a need for the 
interventionists who place the lines to be aware of and to 
adhere to afore mentioned guidelines. At institutional 
level, policies and protocols that require nephrology 
consultation for any PICC request in patients with CKD 
may be considered and implemented. This may require a 
collaborative approach among physicians from various 
specialties and could be facilitated with electronic alerts 
in hospitals where electronic health records are in use. 
Last but not the least, awareness needs to be created 
among patients suffering from CKD and their family 
members about the potential risks and avoidance of 
PICCs. 
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